Detection of 4'-phosphopantetheine at the thioester binding site for l-valine of gramicidinS synthetase 2  by Stein, Torsten et al.
Detection 
FEBS Letters 340 (1994) 3944 
FEBS 13691 
of 4’-phosphopantetheine at the thioester 
L-valine of gramicidins synthetase 2
LiiQE!u 
LETTERS 
binding site for 
Torsten Stein”, Joachim Vatera,*, Volker Kruftb, Brigitte Wittmann-Lieboldb, Peter Frankec, 
Maria Panicod, Roy MC Dowelld, Howard R. Morrisd 
“Institut fiir Biochemie und Molekulare Biologie, Technische Universitat Berlin, Franklinstr 29, D-10587 Berlin, Germany 
bMax-Delbriick-Zentrum fir Molekulare Medizin, Robert-Riissle Str 10. D-13122 Berlin-Buch, Germany 
‘Institut ftir Biochemie, Freie Universitat Berlin, Thielallee 63, D-14195 Berlin, Germany 
dDepartment of Biochemistry, Imperial College of Science, Technology and Medicine, London S W7 2A r UK 
Received 10 December 1993; revised version received 10 January 1994 
Abstract 
Biosynthesis of gramicidins in Bacillus brevis is catalysed by a multienzyme system consisting of two multifunctional proteins, gramicidins 
synthetase 1 and 2 codified by the grsA and grsB genes, respectively. GramicidinS synthetase 2 shows a modular architecture of four amino 
acid-activating domains each containing a thioester binding motif LGG H/D S L/I highly conserved in its C-terminal region, as demonstrated by 
sequence analysis of the grsB gene [w. Schlumbohm et al. (1991) J. Biol. Chem. 266, 23135-231411. This multienzyme was specifically labeled at the 
thioester binding site of L-valine with [3H]N-ethylmaleimide using a substrate protection technique. After enzymatic digestion a labeled active site 
peptide was isolated in pure form by multistep methodology. This fragment was identified by gas-phase sequencing as the active site peptide of the 
thiotemplate site for L-Val by comparison with the grsB gene sequence. By mass spectrometry in combination with amino acid analysis it was 
demonstrated that a 4’-phosphopantetheine carrier was attached to the active serine in this motif. Our results give evidence that multiple peripheral 
4’-phosphopantetheine carriers are involved in the formation of gramicidins in contrast to a central carrier arm as assumed in the original version 
of the thiotemplate mechanism. A ‘Multiple Carrier Model’ of nonribosomal peptide biosynthesis is proposed. 
Key words: GramicidinS synthetase; Thioester binding site; Affinity labeling; Active site peptide; 4’-Phosphopantetheine; Multiple 
carrier model 
1. Introduction 
GramicidinS is a cyclic decapeptide produced by 
Bacillus brevis ATCC 9999. 
p-Phe - Pro - Val - Orn - Leu 
I I 
Leu - Orn - Val - Pro - n-Phe 
Its biosynthesis is catalysed by gramicidins synthetase 
which is one of the best characterized peptide forming 
multienzyme systems consisting of two multifunctional 
*Corresponding author. Fax: (49) (30) 3142 4783. 
Abbreviations: GS, gramicidins synthetase; GSl, gramicidins synthe- 
tase 1 (phenylalanine racemase, EC 5.1.1.11); GS2, gramicidins synthe- 
tase 2 (condensing, peptide forming multienzyme); Pan, 4’-phospho- 
pantetheine; NEM, N-ethylmaleimide; NES, N-ethylsuccinimido; x, S- 
(IV-ethylsuccinimido)4’-phosphopantetheine; DTE, dithioerythritol; 
OPA, o-phthaldialdehyde; HPLC, high-performance liquid chromatog- 
raphy; FPLC, fast protein (peptide) chromatography; HF-FAB MS, 
high-field fast-atom bombardment mass spectrometry; ES1 MS, elec- 
trospray ionization mass spectrometry; m/z, mass to charge ratio; kV, 
kilovolt. 
enzymes which activate their substrate amino acids in a 
two-step process involving aminoacyl adenylate and 
thioester formation [l-5]. GramicidinS synthetase 1 
(GSl) activates and racemizes phenylalanine and trans- 
fers D-Phe to gramicidins synthetase 2(GS2) which acti- 
vates the other 4 amino acids and catalysis the elongation 
of the growing peptide chain by the participation of 4’- 
phosphopantetheine as a carrier. Recently the entire nu- 
cleotide sequence of the B. brevis grsB gene encoding 
GS2 has been determined [6]. 
The mechanism of nonribosomal biosynthesis of nu- 
merous microbial peptides is compatible with the polyen- 
zyme model suggested by F. Lipmann [7] and the thio- 
template mechanism [l-5]. These models propose that 
(a) amino acid activating domains are arranged in series 
along multifunctional polypeptide chains, (b) each reac- 
tion center of a peptide synthesizing multienzyme is 
equipped with a specific sulfhydryl group to which the 
amino acid substrates are attached as thioesters (thio- 
templates), and (c) the growing peptide chain is assem- 
bled by the action of 4’-phosphopantetheine (Pan) as a 
carrier. In accordance with the polyenzyme model [7] 
four conserved and repeated gene segments grsB I-grsB4 
have been identified in the grsB structure. Analyses of 
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active site peptides of the reaction centers of GS2 for 
thiolation of the substrate amino acids showed that they 
could be attributed to the activation domains of Pro, Val, 
Orn and Leu of this multienzyme [8]. Surprisingly an 
active serine is required for covalent attachment of the 
substrate amino acids instead of a cysteine as originally 
proposed for the thiotemplate mechanism. These serine 
residues are part of a LGGH/DSWI motif which is highly 
conserved in the C-terminal region of each amino acid 
activating domain of the peptide synthetases whose gene 
sequences have been determined so far [6,9-131. The H/ 
DSL/I core of this motif has been identified as the 4’- 
phosphopantetheine binding site of acyl carrier proteins/ 
domains of fatty acid and polyketide synthetases [8]. 
In this publication we show for the first time by mass 
spectrometric analysis that 4’-phosphopantetheine is in- 
deed attached to the reactive serine of the LGGHDSL 
motif at the thioester binding site of r-Val in the second 
domain of gramicidins synthetase 2. Our data provide 
evidence that peptide synthetases contain multiple Pan- 
carriers instead of one central Pan-arm as postulated in 
the original version of the thiotemplate model [5] and 
form the basis of a ‘Multiple Carrier Model’ as a new 
concept of the mechanism of nonribosomal peptide bio- 
synthesis. 
2. Materials and methods 
2. I. Materials 
[ZH]N-Ethylmaleimide was purchased from DuPont (Dreieich, 
FRG). Staphyloroccus aureus VI-protease and TPCK-treated trypsin 
were obtained from Miles/Bayer Diagnostics (Miinchen, Germany) and 
Sigma (Deisenhofen, Germany). Bacillus brevis ATCC 9999 was cuhi- 
vated in a fumarate/phosphate medium, as reported by Chiu [14]. 
2.2. Enzyme puriJication and assays 
GS2 was purified as published by Vater et al. [15]. Assays for thio- 
ester formation of GS2 with substrate amino acids [16,17] and biosyn- 
thesis of gramicidinS [l&IS] were performed, as described previously. 
2.3. Specific labeling of the thioester binding site of GS2 for L-valine with 
[3H]N-ethylmaleimide 
30 mg GS2 in 50 ml 400 mM phosphate buffer, pH 7.2, containing 
2 mM DTE and 1 mM EDTA were concentrated to 3 ml by ultrafihra- 
tion. This enzyme solution was dialyzed against a 20 mM phosphate 
buffer, pH 7.2, containing 1 mM EDTA (buffer P) which prior to usage 
was degassed and saturated with nitrogen. 
GS2 was specifically protected at the thiotemplate site of L-valine by 
incubation with 2 mM ATP, 10 mM MgCI, and a saturating L-valine 
concentration of 15 PM for 10 min at 37°C. Reactive groups at the bulk 
of the GSZ-r_-Val-thioester complex were saturated by incubation with 
2 mM NEM for 30 min at 37°C. The resulting complex was isolated 
by gel filtration on Sephadex G-25 at 3°C with buffer P as the eluent 
and concentrated to a final volume of 3 ml by ultrafiltration. By incu- 
bation with 2 mM DTE for 60 min at 37°C L-valine was removed from 
GS2. The enzyme was again isolated by gel filtration (Sephadex G-25; 
3°C; eluent: buffer P) and concentrated by ultrafiltration to 3 ml. For 
all concentration steps an Amicon ultrafilter XM 50 was used. Finally 
the thioester binding site for L-valine was specifically labeled by incuba- 
tion of the deprotected multienzyme with 23 ,uM [‘H]NEM at 37°C for 
30 min. The labeled protein was isolated by gel filtration on Sephadex 
G25 at 3°C with buffer P, pH 8.2 as the eluent and concentrated in a 
Speed Vat concentrator until a final protein concentration of approx. 
2 mg/ml. 
2.4. Digestion of the [‘H]NEM-labeled GS2 with trypsin 
I-2 mg [‘H]NEM-labeled GS2 were digested with 33-66 ,ug TPCK- 
treated trypsin in 0.5-I ml 100 mM phosphate buffer, pH 8.2, contain- 
ing 1 mM EDTA, 10% acetonitrile (v/v) at 37°C for 3 x 60 min. The 
reaction was stopped by adding 500 ~1 0.1% trifluoroacetic acid (v/v). 
The resulting fragments were separated by FPLClHPLC procedures. 
2.5. Digestion of the [‘H]NEM-labeled tryptic jiagments of GS2 with 
Staphyloccus aureus V8 protease 
Tryptic peptides of GS2 labeled with [3H]NEM were dissolved in 200 
,~l ammonium acetate buffer, pH 4.0, containing 1 mM EDTA and 10% 
acetonitrile (v/v). The peptides were digested for 20 h at 37°C with S. 
aureus V8 protease using a molar ratio of protease to substrate of 
approx. 1:lOO. The reaction mixture was dried in a Speed Vat concen- 
trator and separated by reversed phase HPLC. 
2.6. Separation of peptides by reversed phase FPLCIHPLC 
Pharmacia Pro RPC HR 10110 and Pep RPC HR 5/5 FPLC columns 
as well as a Shandon ODS Hypersil(5~) column were used for separa- 
tion of the tryptic fragments. After further digestion with S. aureas 
V8-protease an ODS Hypersil (5~) column was applied for peptide 
purification. 
Peptide mixtures were dissolved in 300 ,uI 0.1% trifluoroacetic acid, 
pH 2.0, loaded onto the columns and eluted with linear gradients of 
acetonitrile. Solvent A was 0.1% trifluoroacetic acid in Hz0 (v/v). Elu- 
ent B was composed of 0.1% trifluoroacetic acid in 80% acetonitrilel 
20% H,O (v/v). The flow rate was 0.75 ml/min. The peptides were 
detected measuring the absorbance at 280 or 214 nm. [‘H]NEM labeled 
active site peptides were monitored by scintillation counting of 5-20 ~1 
aliquots of each fraction. 
2.7. Peptide sequencing 
Peptide sequences were determined on an Applied Biosystems 
pulsed-liquid phase sequencer, model 477 A. Phenylhydantoin amino 
acids were separated on line in an Applied Biosystems model 120 A 
analyzer. Samples were dissolved in 100% trifluoroacetic acid and ad- 
sorbed to a trifluoroacetic acid treated polybrene-coated glass filter that 
had been precycled as described by Hewick et al. [19]. 
2.8. Amino acid analysis 
5&100 pmol of the active site peptide were hydrolyzed with 6 N HCI 
at 110°C for 24 h in sealed, evacuated tubes. The Programmable Mul- 
tidimensional Injection System (Spark, Holland) with automatic pre- 
column derivatization (t = 1 min) was applied for the reaction of the 
amino acids with o-phthaldialdehyde (OPA). OPA-amino acids were 
separated by HPLC on a C18-column (ODS Hypersil (5~), Knauer, 
Germany) using a multistep gradient. Eluent A was 12.5 mM Na2HP0,, 
pH 6.5. Eluent B was 97% methanol and 3% tetrahydrofurane (v/v). 
OPA-amino acids were detected with a Shimadzu-RF-551 Fluores- 
cence-Detector (excitation: 350 nm; emission: 455 nm). 
2.9. Mass spectrometric analysis of the active site peptide 
2.9.1. Fast atom bombardement mass spectrometry (FAB-MS). The 
active site peptide was dissolved in 5% acetic acid and 1 ,uI aliquots 
loaded onto a sample probe treated with 1 ~1 of meta-nitrobenzyl 
alcohol or glyceroUthioglycero1 5/l (v/v) in separate experiments. The 
peptide was then characterized by high-field fast atom bombardment 
mass spectrometry (HF-FABMS) using a Fisons ZAB 2SE2FPD Focal 
Plane Detector instrument equipped with a VG cesium ion gun (30 kV), 
the spectra being acquired on an Opus Data System and calibrated 
using CsI clusters, giving molecular masses based on accurate atomic 
numbers. Initial spectra were recorded on a ZABHF instrument 
equipped with an M-Scan xenon ion gun (10 kV) with spectra recorded 
on oscillographic chart paper, giving molecular masses based on integer 
atomic numbers. Sample aliquots (approx. 50 pmol) were further subdi- 
gested with carboxypeptidase B in 50 mM ammonium bicarbonate 
buffer pH 8.5 for 30 min at 37°C followed by reanalysis in the mass 
spectrometer. 
2.9.2. Electrospray ionization mass spectrometry (ESI-MS). ES1 
mass spectra were recorded on a Finnigan-MAT triple stage quad- 
rupole mass spectrometer TSQ 700 equipped with an electrospray ion 
source. The electrospray needle was operated at a voltage difference of 
4 kV. The peptide material was dissolved in 50:50 mixture of 1% acetic 
acid and methanol (v/v) and introduced into the source at a flow rate 
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of 1 @min. The sample concentrations were in the low pmol@l range. 
Collision activated dissociation experiments were conducted at an en- 
ergy of 17 eV. Argon at a pressure of 3 mtorr was used as the collision 
gas. 
3. Results 
In a previous paper [8] we affinity-labeled GS2 with 
L-[‘4C]valine and L-[14C]leucine at its thioester binding 
sites, isolated active site peptides and showed that a 
serine is involved in the covalent attachment of the 
amino acid substrates to the reaction centers of this mul- 
tienzyme. This direct labeling procedure which is highly 
specific shows some disadvantages. Because the thioester 
complexes of GS2 with its substrate amino acid are sta- 
ble only in acidic media the label was lost in the first 
Edman degradation step during sequencing of the active 
site peptides. Therefore, it was difficult to obtain precise 
information on the nature of the thioester binding sites 
by chemical analysis. On the other hand the choice of the 
techniques for protein fragmentation and separation of 
the complex fragment patterns by multistep HPLC/ 
FPLC methodology is restricted to those techniques 
which can be applied in acidic media. 
To circumvent hese obstacles in this paper we labeled 
the thioester binding site of GS2 for L-valine by an indi- 
rect technique which comprises the following steps: (a) 
substrate protection of the reaction center; (b) saturation 
of the reactive residues at the bulk of the multienzyme 
with high concentrations of nonlabeled NEM; (c) re- 
moval of the substrate amino acid from the thiolation 
site under mild conditions, and finally (d) specific label- 
ing of the thiotemplate site at low concentrations of 
[3H]NEM. In this way a stable GS2-[3H]NEM adduct 
was obtained that allowed the application of the full 
spectrum of fragmentation and separation techniques. 
In order to isolate the active site peptide of the thio- 
template site of GS2 for L-valine we digested the GS2- 
[3H]NEM complex with trypsin. The resulting peptide 
mixture was separated by reversed-phase FPLC/HPLC 
methodology in 3 steps. In the first one the tryptic pep- 
tides were fractionated by reversed phase FPLC on a 
Pharmacia Pro RPC HR lO/lO_column (Cl/C8 alkyl 
chains, pore size: 300 A) in a preparative scale using a 
linear acetonitrile gradient from 0 to 100% eluent B. The 
fractions contaiping the radioactivity were rechromato- 
graphed by reversed-phase FPLC using a Pharmacia Pep 
RPC HR 5/5 column (C2K 18 alkyl chains, pore size: 100 
A) and a more shallow gradient from 20 to 50% eluent 
B for elution. The radioactive material was separated in 
the third step by reversed-phase HPLC on ODS Hypersil 
applying an acetonitrile gradient from 3&60% eluent B 
for 300 min. The radioactively labeled tryptic peptide 
fraction was subsequently digested with Staphylococcus 
aureus V8-protease and fractionated by reversed-phase 
HPLC on ODS Hypersil using an acetonitrile gradient 
from 20 to 50% eluent B. The pure radiolabeled peptide 
isolated in this way was analyzed by gas phases sequenc- 
ing, amino acid analysis and mass spectrometry. By gas 
phase sequencing the following heptapeptide was ob- 
tained: 
1 2 3 4 5 6 7 
L-G-G-H-A/-L-R (1) 
It is identical with the fragment that we have previously 
identified as the active site peptide of the thioester bind- 
ing site for L-valine by direct labeling of GS2 with L- 
[14C]valine. This is confirmed by sequence comparison of 
this fragment with the corresponding segment in the 
grsB2 domain of this multienzyme [8]. However, the gene 
sequence claims a serine at position 5 which is in accord- 
ance with the amino acid analysis data shown in Table 
I. Surprisingly also in the case of alkali-stable modifica- 
tion of the thioester binding site of L-Val with [3H]NEM 
the radioactivity was eliminated from the peptide in the 
first Edman degradation step and a dehydroalanine ap- 
peared in position 5. This implies that the tracer is not 
directly bound to the amino acid residue at this position 
and corroborates our previous hypothesis [8] that an 
additional structural element, possibly a 4’-phosphopan- 
tetheine carrier, is attached to the reactive serine of the 
HSL core. This is confirmed by our amino acid analysis 
data showing that one mole of the active site heptapep- 
tide contains approximately one mole /3-alanine (see 
Table I). To clarify this fundamental question in detail 
Table 1 
Amino acid analysis of the active site peptide for L-valine thiolation of 
GS2 
Amino acid Residue per peptide molecule 
(a) Experimental (b) derived from gene 
sequence 
Leu 
Gly 
Ser 
His 
Arg 
Ala 
Asx 
Glx 
Val 
Ile 
Thr 
Tyr 
Met 
Phe 
Lys 
B-Ala* 
2.0 2 
2.0 + 0.1 2 
0.9 + 0.1 1 
0.9 ?r 0.1 1 
1.0 + 0.1 1 
0.30 f 0.05 
0.08 + 0.02 _ 
0.13 + 0.02 _ 
0.10 + 0.02 
0.08 f 0.02 
0.03 f 0.01 _ 
0.01 _ 
0.01 _ 
_ _ 
_ 
1.3 + 0.2 _ 
The content of the constituent amino acids was referred to the amount 
of L-leucine. Amino acid analysis was performed as indicated under 
Methods. *p-Ala is a constituent of the 4’-phosphopantetheine substit- 
uent. 
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Fig. 1, HF-FABMS spectrum of the active site peptide for L-valine thiolation of GS2 showing an intense quasi-molecular [M,+H]’ ion at m/z = 1204 
together with related fragment ions. The spectrum is drawn from an oscillographic recording. For interpretation see the text. 
it was investigated by mass spectrometric techniques. A 
quasi-molecular ion [M, + H]’ was determined for the 
active site peptide by HF-FABMS at m/z = 1204 Da, as 
shown in Fig. 1. This mass is appreciably higher than the 
739 Da as was calculated from the gene-derived se- 
quence. The mass difference of 465 Da corresponds ex- 
actly to a covalent substitution of the peptide with a 
S-(N-ethylsuccinimido)~4’-phosphopantetheine adduct 
(NES-Pan). The much weaker quasi-molecular ion signal 
at m/z 1079 corresponds to the 4’-phosphopantetheinyl 
peptide itself, i.e. a proportion of molecules not carrying 
the NES label. The nature, covalent linkage and site of 
location of the NES-Pan substituent on the serine residue 
was proven by interpretation of the fragmentation data 
in Fig. 1 according to rules defined by us in earlier work 
[20,21] on both known and unknown peptide sequences. 
The fragmentation pattern observed for the active site 
peptide adduct is a series of N- and C-terminal sequence 
ions (b, c, y and z) at m/z 825, 840; 917; 934; 977; 1030; 
1034 and 1047 which, together with MS data on the 
carboxypeptidase B-treated sample showing removal of 
a free C-terminal arginine residue (156 Da) via a signal 
at m/z 1048, determine the structure of the active site 
heptapeptide summarised in (2) below. These results 
clearly demonstrate that the NES-Pan substituent must 
be attached at the serine residue of the thioester binding 
motif. 
Results of electrospray mass spectrometry measure- 
917 1030 
L +, l-l $I$$R++H1+=1z04 (2) 
1034 977 840 
Y5 Y4 Y3 
x = S-(N-ethylsuccinimido)4’-phosphopantetheine 
ments are shown in Fig. 2. They are complementary to 
the HF-FABMS data. The ES1 mass spectrum (Fig. 2A) 
shows signals at mlz = 603.0 and 402.3 that can be inter- 
preted as the doubly and triply charged active site hep- 
tapeptide [M, + 2H]‘+ and [M, + 3H13+. A molecular 
mass M, of 1204.0 ? 0.3 was calculated using a deconvo- 
lution algorithm [22] and average mass numbers. M, 
matches exactly with the m/z value obtained by FABMS. 
The doubly charged ion at m/z = 603.0 was collision acti- 
vated. The ES1 tandem MS spectrum is shown in Fig. 2B. 
Fragment ions at m/z 819.3 and 721.5 were detected. 
They can be attributed to the phosphorylated heptapep- 
tide and the dehydrated species howing a dehydroalan- 
ine in position 5 which originate from partial or complete 
elimination of the NES-4’-phosphopantetheine substitu- 
ent. In addition fragments were obtained at mlz = 484.5 
and 386.0 that represent he eliminated carrier ion with 
and without phosphate, resp. By increasing the sensitiv- 
ity of the mass spectrometric detection in the m/z range 
between 400 and 710 N-terminal and C-terminal frag- 
ments (y and c series) of the phosphorylated heptapep- 
tide ion [M,+H]’ were observed. From these data struc- 
ture 3 was derived which is consistent with the amino 
acid sequence determined for the active site peptide by 
gas phase sequencing (1) and FABMS (2). The electro- 
spray data demonstrate that the phosphoryl group is 
located on the serine residue corroborating the attach- 
ment of the Pan-carrier at this position. 
7049 6487 5926 455.0 
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Fig. 2. (A) Electrospray ionization mass spectrum of the active site peptide for L-valine thiolation of GS2. The ions at m/z = 603.0 and 402.3 correspond 
to the doubly and triply charged heptapeptide [M,+2H]” and [M,+3H]“. This interpretation is supported by the appearance of the minor signals 
at m/z = 614,625,633 and 410/415 which represent doubly or triply charged Na’lK’ adducts of the heptapeptide M,, as [M,+Na+H]“, [M,+K+H]“, 
[M,+2NaJ2’, [M,+Na+K]*’ and [M,+Na+2H]” as well as [M,+K+ZH] ‘+ for example. Insert: Computer analysis of the ES1 mass spectrum. A , 
molecular mass of 1204.0 + 0.3 was calculated by a deconvolution algorithm [22]. (B) ESI-tandem mass spectrum of the active site peptide for L-valine 
thiolation of GS2. A collision induced fragment ion spectrum of the doubly charged peptide at m/z = 603.0 is shown. The enhancement of the minor 
signals at a higher sensitivity of the instrument allowed a nearly complete assignment of the structure relevant ions (see the text). 
4. Discussion 
In a previous paper [8] we provided evidence from 
chemical and genetic studies that an active serine is in- 
volved in covalent binding of the substrate amino acids 
at each reaction center of gramicidins synthetase 2 in- 
stead of a cysteine as proposed by the original version 
of the thiotemplate mechanism [l-5]. This serine is part 
of a strictly conserved LGGWDSL/I motif which has 
been detected at the C-terminal region of each amino 
acid activating domain of multifunctional peptide syn- 
thetases the gene sequences of which have been deter- 
mined so far. However, the chemical features of the reac- 
tive intermediates are consistent with the existence of 
44 
thioester bonds [l-5,8]. Therefore, it seems unlikely that 
the substrate amino acids of GS2 are directly bound to 
these serine residues at the reaction centers. This conclu- 
sion is supported by the strong similarity of the H/DSL 
core of the thiotemplate motifs of GS2 with 4’-phospho- 
pantetheine binding sites of fatty acid and polyketide 
synthetases [8]. 
In this paper we present experimental evidence for this 
hypothesis for the first time by sequence-, amino acid- 
and mass spectrometric analysis of the active site peptide 
of the thioester binding site of GS2 for L-valine which has 
been labeled with [3H]NEM using the substrate protec- 
tion technique. Our data which prove that a Pan-carrier 
is indeed attached to the active site serine represent a 
fundamental contribution to the elucidation of the mech- 
anism of enzymatic peptide biosynthesis. From our re- 
sults we conclude that multiple 4’-phosphopantetheine 
residues are involved in the biosynthesis of gramicidins 
and numerous other bioactive peptides. These carriers 
are attached to the central serine of the H/DSL core of 
the thioester binding motif at the reaction centers of 
peptide synthetases forming the thiolation sites for the 
substrate amino acids. Therefore, the original version of 
the thiotemplate mechanism has to be replaced by a 
‘Multiple Carrier Model’. Kleinkauf et al. [5] originally 
postulated that bioactive peptides would be assembled in 
a series of transpeptidation and transthiolation reactions 
by interaction of the sulthydryl group of a central 4- 
phosphopantetheine swinging arm with the peripheral 
cysteines at the reaction centers. Our results demonstrate 
that these thiols have to be replaced by peripheral Pan- 
carriers which are the essential mobile elements in the 
dynamics and catalysis of peptide biosynthesis. 
If peptide synthetases are equipped with multiple Pan- 
carriers the postulation of a central swinging arm would 
not be necessary. In this case a simpler model could be 
suggested assuming that the peptide chain is formed in 
a series of transpeptidation steps by interaction of the 
Pan-carriers at the reaction centers. The transthiolation 
reactions which had to be adopted in the original version 
of the thiotemplate model for the transport of the peptide 
intermediates could be omitted. Also the charging of a 
multienzyme with all intermediates of the growing pep- 
tide chain simultaneously could be easily understood 
under these conditions. For the experimental verification 
of the ‘Multiple Carrier Hypothesis’ the precise determi- 
nation of the number of the 4’-phosphopantetheine car- 
riers of GS2 by specific labeling of all reaction centers 
followed by analysis of the active site peptides is needed. 
Also the factors determining the unidirectional assembly 
of the peptide product are still unknown. Here specific 
recognition elements at the elongation sites and/or con- 
T Stein et al. I FEBS Letters 340 (1994) 3944 
formational changes in concert with the transpeptidation 
steps are discussed. The investigation of these questions, 
answers to which are essential for the elucidation of the 
mechanism of nonribosomal peptide biosynthesis, is in 
progress. 
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